|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Grant | |||||
| Product revenue, net | |||||
| License | |||||
| Total revenues | |||||
| Revenue, net | |||||
| Product revenue, net | |||||
| License | |||||
| Total revenue, net | |||||
| Cost and operating expenses: | |||||
| Cost of sales | |||||
| Research and development expenses, net | |||||
| General and administrative | |||||
| Selling, general and administrative expenses | |||||
| Loss on disposal of property and equipment | |||||
| Impairment of operating lease right-of-use assets and related property and equipment | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Other income, net | |||||
| Foreign exchange gains (losses), net | |||||
| Interest income | |||||
| Interest expense, net | |||||
| Total other income (expenses), net | |||||
| Net loss before income tax | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Foreign currency exchange translation adjustment | |||||
| Unrealized holding gains (losses) on available-for-sale debt securities, net of tax of $0 and $0 | |||||
| Total other comprehensive income (loss), net of tax | |||||
| Total comprehensive loss | |||||
| Basic net loss per ordinary share (in usd per share) | |||||
| Diluted net loss per ordinary share (in usd per share) | |||||
| Weighted-average basic ordinary shares (in shares) | |||||
| Weighted-average diluted ordinary shares (in shares) | |||||
Loading...